- Home
- VNCE vs CLRB Comparison
VNCE vs CLRB Comparison
Compare VNCE & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNCE
- CLRB
- Stock Information
- Founded
- VNCE 2002
- CLRB 2002
- Country
- VNCE United States
- CLRB United States
- Employees
- VNCE N/A
- CLRB N/A
- Industry
- VNCE Clothing/Shoe/Accessory Stores
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- VNCE Consumer Discretionary
- CLRB Health Care
- Exchange
- VNCE Nasdaq
- CLRB Nasdaq
- Market Cap
- VNCE 20.2M
- CLRB 17.5M
- IPO Year
- VNCE 2013
- CLRB N/A
- Fundamental
- Price
- VNCE $3.14
- CLRB $5.14
- Analyst Decision
- VNCE Strong Buy
- CLRB Hold
- Analyst Count
- VNCE 4
- CLRB 2
- Target Price
- VNCE $4.63
- CLRB N/A
- AVG Volume (30 Days)
- VNCE 5.7M
- CLRB 105.0K
- Earning Date
- VNCE 09-10-2025
- CLRB 11-17-2025
- Dividend Yield
- VNCE N/A
- CLRB N/A
- EPS Growth
- VNCE N/A
- CLRB N/A
- EPS
- VNCE N/A
- CLRB N/A
- Revenue
- VNCE $291,286,000.00
- CLRB N/A
- Revenue This Year
- VNCE $1.93
- CLRB N/A
- Revenue Next Year
- VNCE $4.91
- CLRB N/A
- P/E Ratio
- VNCE N/A
- CLRB N/A
- Revenue Growth
- VNCE N/A
- CLRB N/A
- 52 Week Low
- VNCE $1.02
- CLRB $4.11
- 52 Week High
- VNCE $6.89
- CLRB $66.60
- Technical
- Relative Strength Index (RSI)
- VNCE 58.70
- CLRB 45.03
- Support Level
- VNCE $2.83
- CLRB $5.31
- Resistance Level
- VNCE $3.39
- CLRB $6.52
- Average True Range (ATR)
- VNCE 0.38
- CLRB 0.41
- MACD
- VNCE -0.04
- CLRB 0.00
- Stochastic Oscillator
- VNCE 55.56
- CLRB 10.69
About VNCE Vince Holding Corp.
Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.